DSpace Repository

PGI28 Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

PGI28 Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

Bektur, C; Nurgozhin, T; Abdukhakimova, D
URI: https://www.sciencedirect.com/science/article/pii/S1098301515042850
http://nur.nu.edu.kz/handle/123456789/2861
Date: 2015-11-01

Abstract:

Hepatitis C Virus(HCV) is a growing health problem in the world. The aim of this study is to estimate a cost-effectiveness of a triple therapy(TT) with simeprevir compared to a TT with telaprevir for the previously treated with double therapy HCV patients in Kazakhstan.

Show full item record

Icon
Check access options

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)